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Summary
E2F transcription factors play a pivotal role in the reg-
ulation of cellular proliferation and can be subdivided
into activating and repressing family members [1].
Like other E2Fs, E2F6 binds to E2F consensus sites,
but in contrast to E2F1-5, it lacks an Rb binding do-
main and functions as an Rb-independent transcrip-
tional repressor [2–5]. Instead, E2F6 has been shown
to complex with Polycomb (PcG) group proteins [6,
7], which have a well-established role in gene silenc-
ing. Here, we show that E2F6 plays an unexpected
and essential role in the tissue specificity of gene ex-
pression. E2F6-deficient mice ubiquitously express
the -tubulin 3 and 7 genes, which are expressed
strictly testis-specifically in control mice. Like an ad-
ditional E2F6 target gene, Tex12, that we identified,
tubulin 3 and 7 are normally expressed in male germ
cells only. The promoters of the -tubulin and Tex12
genes share a perfectly conserved E2F site, which
E2F6 binds to. Mechanistically, E2F6-mediated re-
pression involves CpG hypermethylation locking tar-
get promoters in an inactive state. Thus, E2F6 is
essential for the long-term somatic silencing of cer-
tain male-germ-cell-specific genes, but it is dispens-
able for cell-cycle regulation.
Results and Discussion
We used a gene-targeting strategy to mutate the
mouse E2F6 gene in embryonic stem (ES) cells. Trans-*Correspondence: christian.hagemeier@charite.de
4 Present address: Max-Delbrück-Center for Molecular Medicine,
Robert-Rössle-Straße 10, D-13122 Berlin, Germany.lation termination codons were introduced in all three
open reading frames (ORFs) after codon 58, and the
genomic sequences encoding the DNA binding domain
were replaced with a neomycin resistance gene (Figure
1A). Correctly targeted clones were identified by South-
ern blotting (Figures 1B and 1C) and used to generate
E2F6 mutant mouse strains. E2F6−/− animals were via-
ble and fertile, were born at the expected Mendelian
frequency, and were of similar size and weight to their
wild-type litter mates (data not shown). E2F6−/− mice
were used to isolate mouse embryonic fibroblasts
(MEF). Western-blot analysis with two independent
anti-E2F6 antibodies identified a major immunoreactive
band, undetectable in extracts derived from E2F6−/−
animals, of the expected size in extracts from wild-type
MEFs and from mouse embryos (Figure 1D). We con-
clude that we have created a null allele of E2F6.
To identify target genes that strictly depend on E2F6
for their expression, we compared the expression pro-
files of wild-type (wt) and E2F6−/− proliferating and qui-
escent MEFs by microarray analysis employing Affyme-
trix gene chips. This identified a number of genes that
were misexpressed in −/− MEFs. Here, we concentrate
on the analysis of two genes, α-tubulin 3 (TUBA3) and
α-tubulin 7 (TUBA7), that display similar DNA se-
quences and encode identical proteins [8]. TUBA3 and
TUBA7 expression was virtually undetectable both in
proliferating and in quiescent control fibroblasts, and
both genes were strongly expressed in E2F6−/− MEFs
(see Table S1 in the Supplemental Data available with
this article online). To validate these data obtained by
microarray analysis, we analyzed mRNAs derived from
MEFs of E2F6−/− and wild-type (wt) animals by RNase
protection assay. TUBA3 and TUBA7 mRNAs were un-
detectable in wt MEFs and strongly upregulated in pro-
liferating and G0 E2F6−/− MEFs (Figure 2A). α-tubulins
are highly expressed in many cell types, and subtype-
specific antibodies do not exist, which impedes a spe-
cific analysis of TUBA3 and TUBA7 proteins. Immuno-
fluorescence analysis with a pan-α-tubulin antibody
revealed neither quantitative nor qualitative differences
in the microtubuli structure of E2F6−/− versus control
MEFs (data not shown).
Expression of the TUBA3 and TUBA7 genes was orig-
inally identified in testis, and these proteins represent
the only tubulin subtypes exclusively expressed in the
male gonads [9]. Despite a high degree of conservation
between different tubulin subtypes, specific needs for
particular tubulin subtypes in particular cell types ap-
pear to exist [10]. Probes that detect eight less-
restricted or ubiquitously expressed tubulin subtypes
were also present on the microarray; these genes, how-
ever, were expressed at similar levels in control and
E2F6−/− MEFs (Table S1). This suggested that E2F6 may
be responsible for specifically silencing TUBA3 and
TUBA7 gene expression in organs other than testis,
thereby enabling a tissue-specific expression pattern
for these genes. To test this further, we prepared RNAs
from various organs derived from both wt and E2F6−/−
mice and analyzed the expression of the TUBA3 and
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1052Figure 1. Targeted Disruption of the Murine E2F6 Gene
(A) Schematic of the partial wild-type E2F6 allele, the targeting vec-
tor used, and the recombined E2F6 allele. Exons 3–6 are indicated
as filled boxes, and intron sequences as lines. Exon 4 encodes the
DNA binding domain and was replaced by the neomycin resistance
cassette (neo). The 5# arm of the targeting vector is a 7.5 kb SmaI/
Bst1107I restriction fragment. The 3# arm was generated by PCR
(H, HpaI; S, SmaI; BI, Bst1107I; and BII, BglII). The positions of
oligonucleotide primers used for the genotyping of animals are in-
dicated by arrowheads.
(B) Homologous recombination in ES cells was controlled by F
Southern analysis of BglII-digested genomic DNA with the indi- t
cated 3# probe. (
(C) Positive clones were validated by hybridization of HpaI- (
digested DNA with the 5# probe to control for single-copy integ- t
ration of the long arm. b
(D) To confirm the absence of the E2F6 protein in animals, we per- n
formed Western-blot analysis of extracts from E2F6−/− and wt e
MEFs and embryo heads with two independent antibodies (kindly M
provided by J. Lees, Massachusetts Institute of Technology) recog- (
nizing different epitopes of E2F6. T
i
c
TUBA7 genes (Figure 2B). In control animals, TUBA3 T
and TUBA7 expression was readily detected in testis T
f(top left) but absent or only marginally detectable in
aother organs, such as the liver, spinal cord, placenta,
tspleen, heart, skeletal muscle, and brain. At the same
Ptime, all of these tissues, including testis, concomit-
d
tantly expressed E2F6. In E2F6−/− mice, TUBA3 and
TUBA7 expression had lost its tissue specificity, and
high levels of transcripts were detected in all organs
eanalyzed. In testis, the expression levels of TUBA3 and
TUBA7 were similar in control and E2F6−/− animals (in m
trelation to the β-actin control). This might indicate that
the expression of TUBA3 and TUBA7 in normal testis is [
machieved by preventing the E2F6-mediated repression.
We conclude from this set of experiments that E2F6 is o
oessential for the repression of the TUBA3 and TUBA7
genes in nontesticular tissues, implying a role for E2F6 e
(in establishing tissue-specific patterns of gene ex-
pression. sigure 2. E2F6 Is Required for the Tissue-Specific Expression of
he TUBA3/7 Genes
A) RNase protection assays (RPA) for TUBA7 (left) and TUBA3
right) expression in MEFs. Experiments were performed with ex-
racts from both asynchronously (asyn.) or growth-arrested (G0) fi-
roblasts. L32 was included as an internal control, and tRNA as a
egative control. Undigested probes as indicated. A representative
xample of several experiments with independent preparations of
EFs is shown.
B) E2F6 deficiency results in the derepression of tissue-specific
UBA3 and TUBA7 gene expression. RNA was prepared from the
ndicated organs (sk. muscle = skeletal muscle) of both E2F6-defi-
ient (−/−) and wt animals. Combined analysis of TUBA3 and
UBA7 transcripts was performed by semiquantitative RT-PCR.
he triangles indicate increasing numbers of rounds of PCR ampli-
ication (cycles). All primer pairs were selected so that sense and
ntisense primers anneal to sequences on adjacent exons to con-
rol for the amplification of genomic DNA. A β-actin internal control
CR was included in all samples. Expression of E2F6 mRNA as in-
icated.A recent study found the TUBA3/7 genes not to be
xpressed in somatic cells of the testis but rather in
ale germ cells, namely the spermatogonia that consti-
ute the self-renewing, mitotic germ cells of the testis
11]. The same study also described several other sper-
atogonia-expressed genes that were not represented
n the Affymetrix microarray used here. Out of this set
f genes, we found the Tex12 gene (for testis-
xpressed 12) to be also derepressed in E2F6−/− MEFs
Figure 3A). In contrast, the expression of several other
permatogonia-expressed genes was absent from both
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1053Figure 3. E2F6 Is Required for the Somatic Repression of Germ-
Cell-Specific Gene Expression but Is Dispensable for the Regula-
tion of Classical E2F Response Genes
(A) The indicated germ-cell-specific genes were analyzed by semi-
quantitative RT-PCR for their expression in asynchronously (asyn.)
growing and G0-arrested wt and E2F6−/− MEFs or in testis.
(B) Expression of the indicated E2F target genes in asynchronously
growing cells was monitored by semiquantitative RT-PCR analysis.
Low (L) and high (H) concentrations of template cDNAs were used
along with increasing numbers of rounds of PCR amplification (tri-
angles) as indicated. Amplification of β-actin was used as a posi-
tive control. As a negative control, the reverse transcriptase was
left out of the template reaction mix (-RT).
(C) Cell-cycle distribution of asynchronously growing MEFs. Re-
sults of three independently prepared MEF lines are shown. Experi-
ments were performed at least three times. Columns indicate mean
values with standard deviations shown (error bars).
(D) MEFs were synchronized by serum starvation, and their ability
to reenter the cell cycle after serum readdition was analyzed by
BrdU incorporation over time. Results of two independently MEF
lines are shown. Experiments were performed at least three times.
Columns indicate mean values with standard deviations shown (er-
ror bars).E2F6−/− and wt MEFs but well detectable in testis (Fig-
ure 3A; data not shown). The Tex12 gene encodes a
protein of unknown function with an estimated size of
15 kDa and a 90% conservation between human and
mouse. Thus, more specifically, E2F6 appears to si-
lence a subset of germ-cell-specific genes in somatic
cells.
E2F6 has previously been shown to physically asso-
ciate with a number of canonical E2F-responsive genes
such as Cdc6, E2F1, or TK in vivo [6, 12]. However, in
this study none of these genes were found deregulated
either in asynchronously proliferating or in serum-
starved E2F6−/− MEFs (Figure 3B; data not shown). In
addition, a further set of genes (including BRAC1,
RbAP48, and HP1α) that had also been shown by chro-
matin immunoprecipitation (ChIP) to be occupied by
E2F6 in vivo was similarly expressed in wt and E2F6−/−
fibroblasts (data not shown). Consistent with thesedata, our microarray analysis also did not identify typi-
cal E2F target genes to be deregulated in E2F6-defi-
cient MEFs. Therefore, our data suggest that E2F6 is
not required for the regulation of an E2F-driven pro-
gram of cell-cycle-dependent gene expression. This is
further supported by the finding that the overall cell-
cycle control of E2F6−/− MEFs is unperturbed when
compared to wt MEFs (Figure 3C; data not shown).
Also, both cell types reentered the cell cycle after se-
rum starvation with similar kinetics (Figure 3D), which
is consistent with a previous study [13]. In conclusion,
E2F6 is not required for the correct expression of E2F-
responsive cell-cycle genes.
The TUBA3 and TUBA7 promoters are well con-
served and lack canonical TATA sequences (Figure 4A).
As shown by RNase protection assay, the TUBA3 pro-
moter contains two major transcription start sites at
positions –103 and −71 in relation to the translation ini-
tiation codon (Figure 4A). This is consistent with the
sequence of EST clones found in the National Center
for Biotechnology Information (NCBI) databank. Both
promoters contain conserved transcription factor bind-
ing sites such as CCAAT (C/EBP, NF-Y) and Myb ele-
ments that have been shown to serve as positive sites
in the E2F-responsive cdc2 and cyclin B gene promot-
ers [14]. The TUBA3 and TUBA7 promoters also contain
a single E2F consensus binding site that is located in a
conserved position at approximately 180 bp upstream
of the major transcription start sites. This E2F site is
identical in the mouse TUBA3 and TUBA7 genes, in the
testis-specific human TUBA3/7 homolog, TUBA2 [15],
and in two primate TUBA3/7 homologs that were iden-
tified in the NCBI databank by homology search (Figure
S1). The Tex12 gene also contains this very E2F site (at
position −98 in relation to the transcription start site),
and, interestingly, this particular binding site perfectly
reflects the high-affinity E2F6 binding element that we
identified in a binding site selection assay with bacteri-
ally expressed E2F6 and DP1 proteins (Figure 4B). This
high-affinity binding site is characterized by a core ele-
ment that in all of the 28 distinct clones we identified
in the selection assay displays the sequence TCCCGC
followed by a C or G. Also, the core is typically flanked
on one or both sides by a poly A or poly T stretch (Fig-
ure S2).
To determine whether the E2F consensus site is of
functional significance for the E2F6-mediated regula-
tion of the α-tubulin promoters, we first analyzed the
ability of E2F6 to interact with this site in DNA bandshift
assays. With extracts from HeLa cells, the TUBA7 E2F
site was recognized by two endogenous protein com-
plexes that contain heterodimers of DP1 and either
E2F1, E2F3, or E2F4 (“free E2F”), as shown by “su-
pershift” experiments (Figure 4C; data not shown). In
contrast, no binding of endogenous E2F6 protein was
detected by this approach, although recombinant HA-
tagged E2F6 readily binds to the wt (Figure 4C, lane 2)
but not to a mutant TUBA3 E2F recognition sequence
(lane 3) and can be “supershifted” by an anti-HA anti-
body (lane 4). Similarly, overexpressed E2F4 binds to
the wt but not the mutant probe and comigrates with
the slowest of the “free E2F” complexes.
E2F6 is contained in large complexes [6]. DNA bind-
ing of endogenous E2F6 has not been demonstrated in
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Figure 4. Testis-Specific E2F6 Target Genes Contain a Conserved
E2F Site that Serves as a High-Affinity E2F6 Binding Site
t(A) Promoter sequences of the TUBA7 and TUBA3 genes were re-
trieved from the NCBI databank (accession numbers NT_085812 (
pand AC140324). Minor (arrow) and major (bold arrow) transcription
start sites were determined by ribonuclease protections assay a
C(RPA; not shown). Numbering is according to the TUBA3 sequence,
with −1 being the first nucleotide upstream of the translation initia- c
ition codon (ATG). Conserved NF-Y, Sp1, and Myb binding sites are
underlined, and the E2F site is boxed. p
((B) The E2F site identified in a binding site selection assay as a
high-affinity E2F6 binding element (sel. site) is aligned with the E2F t
Tsites from the TUBA3, TUBA7, and Tex12 promoters. Identical nu-
cleotides among all sites are shaded (also see Figure S2 for details b
ton the binding site selection assay).
(C) Gel mobility shift assays were performed with whole-cell ex- aThe finding that the TUBA3 promoter is obviously not
racts from HeLa cells transfected with control (lane 1), HA-tagged
HA) E2F6 (E2F6, lanes 3–4), or E2F4 (lanes 5 and 6) expression
lasmids. The E2F binding site of the TUBA7 promoter was used
s probe. In lanes 3 and 6, the E2F site was mutated (TTC
CGCCAAA to TTCTTAACAAA). “Free E2F” complexes are indi-
ated by a bracket. The E2F6-specific complex (closed arrowhead),
ts “supershifted” form (open arrowhead), and nonspecific com-
lexes (asterisks) are indicated.
D) Aliquots of the same wild-type and mutated E2F oligonucleo-
ides used in (B) were covalently coupled to a sepharose column.
he column was loaded with extracts from HEK293 cells under
inding conditions. After being washed (lanes 2 and 7), bound pro-
eins were eluted with high-salt buffer (lanes 3–5 and 8–10) and
nalyzed by immunoblot with specific antibodies as indicated.band shift assay to date, possibly owing to the insta-
ility of such complexes under electrophoresis condi-
ions. To overcome this limitation, we covalently cou-
led double-stranded DNA oligonucleotides containing
he TUBA7 E2F binding site (or a mutant site) to sepha-
ose and used this for affinity chromatography. The af-
inity-chromatography columns were loaded with whole-
ell extracts (Figure 4D, lane1) and washed. Bound
roteins were eluted with high salt and analyzed by
estern blotting. Under these experimental conditions,
n interaction of endogenous E2F6 with the wt (lanes
–5) but not the mutant (lanes 7–10) TUBA7 E2F site
an readily be observed. In addition, E2F4 also binds
o the column in an E2F-site-specific manner, but the
nrelated transcription factor Sp1 does not. Thus, both
verexpressed and endogenous E2F6 can specifically
ind to the TUBA3 E2F site.
Given that several E2F family members are able to
ind to the TUBA3 E2F site in vitro, we next analyzed
he occupancy of this site in vivo. Employing the geno-
ic footprinting methodology [16], we show that at
imes when this promoter is active in E2F6−/− MEFs,
he E2F site is protected, indicating the association of
ndogenous transacting factors with this DNA element
Figure 5A). Also, additional footprints protecting a
CAAT box and a predicted Sp1 binding site clearly
ndicate that the TUBA3 promoter (including the E2F
ite) is bound by sequence-specific factors in vivo. In
ontrast, none of these sites were occupied to a signifi-
ant degree in wt MEFs, and, moreover, no other pro-
ected sequence elements could be detected. In addi-
ion, the hypersensitive site observed in E2F6−/− MEFs
t position −148 was absent from the repressed pro-
oter. These data indicate that in wt fibroblasts, when
he TUBA3 gene is silent, the promoter is not occupied
o an appreciable extent by transacting factors but that
t “opens up” in E2F6−/− MEFs, leading to factor acces-
ibility that in turn correlates with active transcription.
onsistent with the lack of E2F site occupancy of the
epressed TUBA3 promoter, we were unable to detect
ignificant E2F6 (or E2F1) binding to the TUBA3 pro-
oter in wt fibroblasts by ChIP (Figure 5B). However,
e could readily detect binding of the transactivating
actors E2F1 and Sp1 to the TUBA3 gene promoter in
2F6−/− MEFs (Figure 5B), which is again in close
greement with the in vivo footprinting pattern and the
ctivity of the TUBA3 promoter in these cells.
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1055Figure 5. TUBA3 Promoter Occupancy and Protein Interaction
In Vivo
(A) Genomic footprinting of the TUBA3 promoter in wt and E2F6−/−
MEFs. E2F6−/− and wt MEFs were treated with dimethylsulfate
(DMS) to analyze the occupancy of transcription factor binding
sites in vivo. Modified genomic or naked (N-DNA) DNA was sub-
jected to piperidine cleavage that induces strand brakes at DMS-
methylated guanosine residues. The sense strand of the TUBA3
promoter was analyzed by ligation-mediated PCR (LMPCR) starting
from –67 in relation to the ATG start codon. Transcription factor
binding sites for E2F, NF-Y (C/EBP), NF-1, and Sp1 as well as pro-
tected (open arrowheads) and hypermethylated guanosine resi-
dues (filled arrowheads) are indicated.
(B) In vivo binding of transcription factors to the mouse TUBA3
promoter. Extracts were prepared from formaldehyde-treated
E2F6−/− and wt MEFs and, after sonification, crosslinked chromatin
was precipitated with antibodies directed against E2F1, E2F6, and
Sp1 or in the absence of antibodies (no Ab). After de-crosslinking,
TUBA3 promoter fragments were either amplified from the precipi-
tated material or from the pre-precipitation input material (input).
(C) Restriction enzyme/PCR analysis of the methylation state of the
TUBA3 promoter in E2F6−/− and wt MEFs. The methylation status
of the TUBA3 and Cdc6 genes was analyzed by restriction enzyme
PCR. Genomic DNA from E2F6−/− and wt MEFs was incubated with
the methylation-sensitive restriction endonuclease AciI, and then
promoter sequences were PCR amplified. The amplified TUBA3
and Cdc6 promoter fragments each contain two AciI recognition
sites.
(D) E2F6-dependent switch in TUBA3 promoter methylation. The
individual CpG methylation status of the TUBA3 promoter in
E2F6−/− and wt MEFs was analyzed by bisulphite sequencing. So-
dium-bisulphite-modified DNAs were PCR amplified, and TUBA3
promoter fragments covering sequences from −175 to +121 in rela-
tion to the ATG start codon were subcloned. The TUBA3 promoter
is schematically shown in the top panel with the E2F site and the
ATG start codon indicated. Small vertical lines represent CpG dinu-MEFs. Third, in contrast to Cdc6, which shows contin-
cleotides, of which 17 are located in the indicated amplified pro-
moter fragment. The methylation state of each of these CpG dinu-
cleotides was determined in ten independent clones by direct se-
quencing. Methylated CpGs of the TUBA3 promoter fragments are
shown as black (from wt MEFs) or gray (from E2F6−/− MEFs)
squares. Open squares indicate nonmethylated CpG dinucleotides.occupied by transacting factors in E2F6−/− fibroblasts
suggested to us that in wt fibroblasts, the repressed
TUBA3 gene might be DNA methylated and hence in
an inaccessible state for specific DNA binding proteins.
Consistent with this notion, the TUBA3 promoter con-
tains a predicted (EMBL-EBI EMBOS CpGPlot) CpG is-
land spanning the proximal promoter and the first exon.
A single CpG dinucleotide is also located within the E2F
site. In order to directly analyze the state of DNA meth-
ylation of the TUBA3 gene, we first performed a restric-
tion digest analysis of genomic DNAs with the meth-
ylation-sensitive endonuclease AciI followed by PCR
amplification of a promoter fragment encompassing
nucleotides −370 to +9 in relation to the ATG start co-
don. This region contains two AciI recognition sites,
one of them overlapping the E2F binding element. In
the absence of the AciI digestion (−AciI), the TUBA3
and a Cdc6 control promoter could readily be amplified
by PCR (Figure 5C). However, AciI digestion prevented
amplification of the Cdc6 promoter, indicating its non-
methylated state in both E2F6−/− and wt MEFs. In con-
trast, AciI treatment (+AciI) did not hamper amplifica-
tion of the TUBA3 promoter from wt MEFs, suggesting
that this promoter (including the E2F binding site) is
methylated in wt fibroblasts. Because DNA methylation
of E2F sites has been shown to interfere with E2F DNA
binding [17], these data also help to rationalize the lack
of E2F site occupancy of the repressed TUBA3 pro-
moter described above. Importantly, in E2F6−/− MEFs,
methylation of the TUBA3 promoter was found to be
severely reduced, as indicated by an approximately
8–10-fold decrease in the efficiency of promoter ampli-
fication (Figure 5C). The majority of CpG dinucleotides
of the amplified TUBA3 promoter region were methyl-
ated in wt MEFs. Strikingly, in E2F6−/− MEFs, the situa-
tion was reversed, with the majority of CpGs being
nonmethylated (Figure 5D). This result is not only con-
sistent with the above data but also with the state of
TUBA3 promoter activity in these cells. Together, these
data show that E2F6 is essentially required for the epi-
genetic imprint of the repressed TUBA3 gene and that
this imprint is lost from the TUBA3 promoter in E2F6−/−
MEFs in which this gene is highly expressed.
Downregulation of TUBA3-like genes by E2F6 is evi-
dently distinct in many ways from the E2F6-mediated
repression of Cdc6-like genes. First, TUBA3 (and also
TUBA7 and Tex12) is completely silenced by E2F6,
whereas downregulation of Cdc6-like cell-cycle genes
by E2F6 in S phase is “leaky” [12]. Second, TUBA3-like
target-gene repression essentially depends on E2F6,
whereas the loss of E2F6 can be compensated for by
E2F4 in the repression of the Cdc6 gene [12]. In fact,
we found none of the typical cell-cycle-dependent E2F
target genes analyzed here to be deregulated in E2F6−/−
Current Biology
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Rrepressed state [18], the silenced TUBA3 promoter is
Acharacterized by a severely reduced accessibility for
P
transacting factors, resulting in a “locked promoter
state.” Fourth, again in contrast to Cdc6 promoter regu-
Rlation, in which we did not find evidence for DNA meth-
ylation, TUBA3 is heavily DNA methylated in the re-
pressed state. Thus, there seem to exist at least two
classes of E2F6 target genes, one class reflecting clas-
sical cell-cycle-regulated genes, such as Cdc6, that do
not strictly depend on E2F6, and another class so far
comprising the male germ-cell-specific α-tubulin and
Tex12 genes that all have a cell-type-restricted expres-
sion pattern and that are permanently switched off with
the help of E2F6. Silencing of the latter class of genes
involves DNA methylation resulting in a locked pro-
moter state with a severely reduced accessibility for
transacting factors. Interestingly, DNA-methylation-based
restriction of gene expression has also been shown for
the testis-specific follicle-stimulating hormone recep-
tor gene in males [19] and for the endothelial-cell-
restricted expression of the endothelial nitric-oxide
synthase gene [20], suggesting that DNA methylation
might be a common mechanism for cell-type-depen-
dent long-term silencing of specific genes.
The existence of two classes of E2F6 target genes is
reminiscent of findings described for the repressive E2F
(dE2F2) in Drosophila. Although dE2F2 does associate
with numerous cell-cycle-regulated E2F target genes
in vivo, it is not strictly required for their regulation. In-
stead, dE2F2 has important and nonredundant func-
tions in the repression of gender-, developmental-, and/
or differentiation-specific genes [21]. Mouse TUBA3
and 7 as well as Tex12 likely constitute examples of
such E2F target genes in mammals, and further genes
are likely to be identified. Consistent with this view,
1E2F6-deficient mice were reported to have a develop-
mental defect displaying a mild homeotic transforma-
tion [13]. Therefore, the long-term silencing of gender- 1
and developmental-specific genes appears to be a
conserved function of repressive E2Fs from Drosophila
1to mammals. In contrast to dE2F2, repression by E2F6
is Rb-independent and can involve instead the recruit-
ment of PcG repressor complexes [22]. Whether PcG
proteins are also involved in the repression of testis- 1
specific E2F6 target genes remains to be seen. How-
ever, a switch in the recruitment of repressor com-
plexes may be advantageous for uncoupling the control
1of those types of E2F response genes that need to be
silenced in a long-term manner from the cell-cycle-con-
trolled activity of Rb-dependent repressor complexes. 1
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1
Detailed Experimental Procedures, as well as two supplemental fig-
ures and a supplemental table, are available at http://www.current-
biology.com/cgi/content/full/15/11/1051/DC1/.
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